Home » kif18a targeted therapy market

Request Sample
6491

Order Summary

Report Title
kif18a-targeted-therapy-market KIF18A Targeted Therapy Market By Indication (Ovarian Cancer, Triple-Negative Breast Cancer, NSCLC, Colorectal, Other Solid Tumors); By Line of Therapy (First-Line, Second-Line, Third-Line+); By Biomarker (CIN-High, CIN-Low, Other); By Combination (Monotherapy, With Checkpoint Inhibitors, With Chemotherapy); By End-User (Oncology Centers, Research Institutions); By Region, Launch Pricing & Market Access Economics, 2025–2035
Report Id 59231791
License Type
Buy Now